Health and Fitness Health and Fitness
Tue, October 26, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
ArQule, Inc. to Present at Oppenheimer 21st Annual Healthcare Conference
[ Tue, Oct 26th 2010 ] - Market Wire
PPD Reports Third Quarter 2010 Financial Results
[ Tue, Oct 26th 2010 ] - Market Wire
Incyte to Report Third Quarter 2010 Financial Res .. ug Discovery & Development Programs on November 9
[ Tue, Oct 26th 2010 ] - Market Wire
GTx Announces Proposed Public Offering of Common Stock
[ Tue, Oct 26th 2010 ] - Market Wire
Illumina Announces HiSeq 1000 Sequencing System
[ Tue, Oct 26th 2010 ] - Market Wire
Allos Therapeutics to Report Third Quarter 2010 Financial Results on November 4, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
Healthways and BlueCross BlueShield of Tennessee .. mprove Health, Well-Being of Seniors in the State
[ Tue, Oct 26th 2010 ] - Market Wire
Cubist Pharmaceuticals to Present at November Investor Conferences
[ Tue, Oct 26th 2010 ] - Market Wire
STERIS Corporation to Announce Fiscal 2011 Second Quarter Earnings on November 3, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
CORRECTING and REPLACING Amedisys Reports Third Q .. arter Revenue and Earnings, Updates 2010 Guidance
[ Tue, Oct 26th 2010 ] - Market Wire
ARIAD Announces Pricing of Public Offering of Common Stock
[ Tue, Oct 26th 2010 ] - Market Wire
PPD and Bend Research Enter into Collaboration to .. ion Development and Analytical Testing Capabiliti
[ Tue, Oct 26th 2010 ] - Market Wire
PPD and VirtualScopics Establish Strategic Alliance for Medical Imaging Services
[ Tue, Oct 26th 2010 ] - Market Wire
Obagi Medical Products Announces Proposed Seconda .. ockholders and Authorization to Repurchase Shares
[ Tue, Oct 26th 2010 ] - Market Wire
International Stem Cell Corporation Announces Com .. uring Run of Lifeline Skin Carea?s Stem Cell-Base
[ Tue, Oct 26th 2010 ] - Market Wire
BioSante Pharmaceuticals, Inc. To Present at Two Upcoming Investor Conferences
[ Tue, Oct 26th 2010 ] - Market Wire
MDS Inc. Completes Name Change to Nordion Inc., and Corresponding Change to Stock Ticker Symbols
[ Tue, Oct 26th 2010 ] - Market Wire
Life Technologies Establishes New Standard for Single-Read Accuracy in Next Generation Sequencing
[ Tue, Oct 26th 2010 ] - Market Wire
Biogen Idec Reports Third Quarter 2010 Results
[ Tue, Oct 26th 2010 ] - Market Wire
Exelixis Announces November 4 Webcast of Third Quarter 2010 Financial Results Conference Call
[ Tue, Oct 26th 2010 ] - Market Wire
Enzon to Release Third Quarter 2010 Earnings on Tuesday, November 2, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
Oncolytics Biotech® Inc. Collaborators Prese .. al Colorectal Cancer Study at the International S
[ Tue, Oct 26th 2010 ] - Market Wire
Compugen Reports Third Quarter 2010 Financial Results
[ Tue, Oct 26th 2010 ] - Market Wire
Amedisys Reports Third Quarter Revenue and Earnings, Updates 2010 Guidance
[ Tue, Oct 26th 2010 ] - Market Wire
Synergetics USA Announces New Products and Record .. rican Academy of Ophthalmology 2010 Annual Meetin
[ Tue, Oct 26th 2010 ] - Market Wire
Cascade Technologies Corporation Announces Appointment of Robert Chave as Chief Technologist
[ Tue, Oct 26th 2010 ] - Market Wire
ICON Announces Appointment of Cathrin Petty to Board of Directors
Mon, October 25, 2010
[ Mon, Oct 25th 2010 ] - Market Wire
Sanofi-aventis Initiates Phase III Study with Ter .. with Interferon Beta to Further Explore Clinical
[ Mon, Oct 25th 2010 ] - Market Wire
Peoplefirst Rehabilitation Announces New Multi-State Contracts for Therapy Services
[ Mon, Oct 25th 2010 ] - Market Wire
Geron Announces Conference Call to Discuss Financial Results for the 2010 Third Quarter

Geron Announces Conference Call to Discuss Financial Results for the 2010 Third Quarter


Published on 2010-10-25 13:40:38 - Market Wire
  Print publication without navigation


MENLO PARK, Calif.--([ BUSINESS WIRE ])--Geron Corporation (Nasdaq:GERN) will announce its financial results for the 2010 third quarter on Thursday, October 28, 2010, after the closing of the equity market. Thomas B. Okarma, Ph.D., M.D., Gerona™s president and chief executive officer, and David L. Greenwood, Gerona™s executive vice president and chief financial officer, will host a conference call for analysts and investors on Friday, October 29, 2010 at 8:00 a.m. Pacific Time, 11:00 a.m. Eastern Time.

Participants can access the conference call live via telephone by dialing 866-730-5770 (U.S.); 857-350-1594 (international). The passcode is 14864744. A live audio-only webcast is also available through a link that is posted on the Events page in the Investor Relations section of Gerona™s Web site at [ http://www.geron.com ]. The audio Web broadcast of the conference call will be available for replay within 60 minutes following the live broadcast through November 29, 2010.

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit [ www.geron.com ].

Contributing Sources